Evidence map›Paper›PMID 39913561›Full record

ArticlePLoS genetics2025

The transmembrane protein Syndecan is required for stem cell survival and maintenance of their nuclear properties.

Buffy L Eldridge-Thomas, Jerome G Bohere, Chantal Roubinet, Alexandre Barthelemy, Tamsin J Samuels, Felipe Karam Teixeira, Golnar Kolahgar

Abstract read
In one paragraph

Article in PLoS genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Buffy L Eldridge-ThomasDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Jerome G BohereDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Chantal RoubinetUniversité de Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes), UMR 6290, ERL U1305, Rennes, France.ORCID https://orcid.org/0000-0002-9335-4523
Alexandre BarthelemyDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Tamsin J SamuelsDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Felipe Karam TeixeiraDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
Golnar KolahgarDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-4007-3311

Funding

Wellcome Trust
6 · The paper itself

Abstract

Tissue maintenance is underpinned by resident stem cells whose activity is modulated by microenvironmental cues. Using Drosophila as a simple model to identify regulators of stem cell behaviour and survival in vivo, we have identified novel connections between the conserved transmembrane proteoglycan Syndecan, nuclear properties and stem cell function. In the Drosophila midgut, Syndecan depletion in intestinal stem cells results in their loss from the tissue, impairing tissue renewal. At the cellular level, Syndecan depletion alters cell and nuclear shape, and causes nuclear lamina invaginations and DNA damage. In a second tissue, the developing Drosophila brain, live imaging revealed that Syndecan depletion in neural stem cells results in nuclear envelope remodelling defects which arise upon cell division. Our findings reveal a new role for Syndecan in the maintenance of nuclear properties in diverse stem cell types.

Indexed as

Drosophila ProteinsStem CellsSyndecansAnimalsBrainCell NucleusCell SurvivalDNA DamageDrosophilaDrosophila melanogasterNeural Stem CellsNuclear EnvelopeNuclear LaminaDrosophila ProteinsSyndecans

Identifiers

PMID39913561
PMCPMC11819509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.